CONSIDINE AND ASSOCIATES, INC. – Trademark Portfolio

Entity Type: 03

CONSIDINE AND ASSOCIATES, INC. holds 5 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 35 (Advertising & Business) — 5 filings in this category. Currently, 4 trademarks are registered. Notable registered marks include HEALTHCLAIM REVIEW, HEALTHCLAIM ADVANTAGE, HEALTHCLAIM SOLUTIONS, and MEDICAL REVIEW SOLUTIONS. The owner is based in LAGUNA HILLS, CA.

25401 CABOT ROAD, SUITE 200

LAGUNA HILLS, CA 92653

5 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

Trademark Classifications

CONSIDINE AND ASSOCIATES, INC.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

35
Advertising & Business (5 filings)

Advertising; business management; business administration; office functions

Frequently Asked Questions

How many trademarks does CONSIDINE AND ASSOCIATES, INC. have?

CONSIDINE AND ASSOCIATES, INC. has 5 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 abandoned.

What trademark classes does CONSIDINE AND ASSOCIATES, INC. file in?

CONSIDINE AND ASSOCIATES, INC. files trademarks across 1 Nice Classification class. The most active classes are Class 35 (Advertising & Business). Class 35 covers advertising; business management; business administration; office functions.

What are CONSIDINE AND ASSOCIATES, INC.'s most well-known trademarks?

CONSIDINE AND ASSOCIATES, INC.'s registered trademark portfolio includes well-known marks such as HEALTHCLAIM REVIEW, HEALTHCLAIM ADVANTAGE, HEALTHCLAIM SOLUTIONS, and MEDICAL REVIEW SOLUTIONS. These are among 4 currently registered trademarks in the portfolio.

What is CONSIDINE AND ASSOCIATES, INC.'s trademark registration success rate?

CONSIDINE AND ASSOCIATES, INC. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 0 applications are pending review.